Balancing seizure control and quality of life: A century of lessons

Notice: Blog posts are not subject to review by MedLink Neurology’s Editorial Board. MedLink acknowledges using artificial intelligence to assist in the creation of blog posts.

In epilepsy management, achieving seizure control is often the primary goal. However, experience has taught us that complete seizure freedom cannot come at the cost of a patient’s quality of life. Over the last century, this realization has guided the evolution of epilepsy treatment, with an increasing focus on balancing effective seizure control with minimizing side effects, addressing comorbidities, and supporting overall well-being. This blog post explores the lessons learned from decades of clinical practice and research, highlighting specific examples of achieving this balance.

In the early days of epilepsy treatment, polypharmacy was a common strategy. Physicians would prescribe multiple antiepileptic drugs in the hope of achieving seizure control, often with limited consideration for the cumulative side effects. This approach frequently resulted in sedation, cognitive impairment, and poor adherence. Over time, studies demonstrated that monotherapy, where a single antiepileptic drug is optimized to control seizures, could provide comparable or better seizure control with fewer side effects. This shift marked a turning point in epilepsy care, emphasizing the importance of minimizing treatment burdens while maximizing efficacy.

One of the most important lessons learned is the need for individualized treatment plans. A one-size-fits-all approach often fails to address the unique needs of individual patients. Advances in understanding seizure types, epilepsy syndromes, and patient-specific factors have highlighted the importance of personalized care. For example, antiepileptic drug selection must consider factors such as age, sex, comorbidities, and lifestyle. Women of childbearing age, for instance, often require alternatives to valproate to minimize teratogenic risks. Additionally, coexisting conditions such as depression or anxiety must be addressed, as they are common in epilepsy patients and can significantly impact quality of life. A patient with focal seizures and a history of depression may benefit from lamotrigine, which has mood-stabilizing properties, rather than levetiracetam, which can exacerbate mood symptoms in some individuals.

For patients with drug-resistant epilepsy or intolerable side effects from antiepileptic drugs, nonpharmacological treatments offer a lifeline. Early skepticism about these therapies led to widespread acceptance as research demonstrated their efficacy. Diets like the ketogenic or modified Atkins diet have been shown to significantly reduce seizures, particularly in children with drug-resistant epilepsy. For example, see “Ketogenic dietary therapy for Dravet syndrome” on the Matthew’s Friends charitable website, which relates the story of a young child with Dravet syndrome, unresponsive to multiple antiepileptic drugs, who experienced a significant reduction in seizures after starting the ketogenic diet, demonstrating how nonpharmacological approaches can transform lives. Neurostimulation therapies, such as vagus nerve stimulation and responsive neurostimulation, provide options for patients who are not candidates for surgery. Additionally, surgery, when appropriate, can offer seizure freedom for patients with focal epilepsy originating from a resectable area of the brain. (Learn more about the Matthews Friends charity at www.matthewsfriends.org.)

Accurate monitoring of seizure activity and treatment side effects is another critical component of balancing seizure control with quality of life. Wearable devices and seizure-detection technology allow for objective tracking of seizures, reducing reliance on self-reports. Telemedicine and mobile apps improve communication between patients and clinicians, enabling real-time adjustments to treatment. Regular assessments of cognitive, emotional, and physical well-being ensure that the broader impacts of epilepsy and its treatment are addressed. For example, a wearable device like the Embrace Watch, combined with the SeizureTracker app, helped a patient identify nocturnal seizures that had previously gone unnoticed. With this data, their neurologist adjusted medication timing, reducing both seizure frequency and daytime drowsiness. (Learn more about this technology at epilepsyawarenessday.org.)

Perhaps the most important lesson learned is the value of patient-centered care. Every patient’s journey with epilepsy is unique, and treatment must align with their personal goals, preferences, and values. Shared decision-making improves treatment adherence and patient satisfaction. When designing treatment plans, clinicians must consider a patient’s quality of life, including their ability to work, drive, and maintain relationships. Addressing stigma and empowering patients through education are also integral to holistic care. A college student with epilepsy prioritized cognitive clarity for academic performance. Switching from a sedating antiepileptic drug to a newer drug with fewer cognitive side effects allowed them to excel academically while maintaining seizure control. (See scepilepsy.org/college for resources for college students with epilepsy.)

The evolution of epilepsy management continues to prioritize the balance between seizure control and quality of life. Emerging technologies, such as artificial intelligence for seizure prediction and pharmacogenetics for personalized medicine, promise to refine this balance even further. As we move forward, the lessons of the past—from minimizing polypharmacy to embracing holistic care—remain foundational to providing the best possible outcomes for people living with epilepsy. Ultimately, the goal is not just seizure control but a life where patients can thrive, free from the burdens of both seizures and treatments. By learning from history and staying at the forefront of innovation, we are ever closer to achieving that vision.

Related MedLink Neurology Blog entry:

• Revolutionizing epilepsy monitoring: From diaries to wearable tech

Are you interested in contributing a post or becoming a guest blogger for MedLink? Contact us at editorial@medlink.com.